Glucocorticoids in lung cancer: Navigating the balance between immunosuppression and therapeutic efficacy

Glucocorticoids in lung cancer: Navigating the balance between immunosuppression and therapeutic efficacy

Blog Article

Glucocorticoids casual azul tequila (GCs), a class of hormones secreted by the adrenal glands, are released into the bloodstream to maintain homeostasis and modulate responses to various stressors.These hormones function by binding to the widely expressed GC receptor (GR), thereby regulating a wide range of pathophysiological processes, especially in metabolism and immunity.The role of GCs in the tumor immune microenvironment (TIME) of lung cancer (LC) has been a focal point of research.As immunosuppressive agents, GCs exert a crucial sepia plex impact on the occurrence, progression, and treatment of LC.In the TIME of LC, GCs act as a constantly swinging pendulum, simultaneously offering tumor-suppressive properties while diminishing the efficacy of immune-based therapies.

The present study reviews the role and mechanisms of GCs in the TIME of LC.